Login to Your Account

Lee's sets sights on dry eye, gets fast track CFDA phase II approval

By Shannon Ellis
Staff Writer

Tuesday, June 24, 2014
SHANGHAI – Another month, another announcement for Lee's Pharmaceuticals Ltd., of Hong Kong, as it has been slowly but surely building a successful biotech business and developing and commercializing products for the China market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription